Çocuklarda paranazal sinüs enfeksiyonlarının değerlendirilmesi

Akut bakteriyel sinüzitin tanısı, uzayan viral üst solunum yolu enfeksiyonu belirtilerine (>10-14 gün) ya da sinüziti gösteren belirgin klinik bulgulara dayanır. Çocuklarda sinüzit tanısı klinik bulgularla konur. Viral ÜSYE sinüzit ile benzer radyolojik bulgulara neden olur, bu nedenle sinüslerin düz grafileri dikkatli yorumlanmalıdır. Radyolojik değerlendirme yineleyen sinüziti olan, sinüzit tanısı kuşkulu bulunan ya da komplikasyon geliştiğinden kuşkulanılan olgularda istenmelidir. Ülkemizde penisiline orta düzeyde dirençli S. .pneumoniae oranı yaklaşık %20-25, yüksek dirençli S. pneumoniae oranı ise yaklaşık %3'tür. H. influenzae da beta laktamaz pozitiflik oranı yaklaşık %8'dir. Tedavide amoksisilin önerilen ilk tercihtir. Ancak yuvaya giden, yaşı

Management of paranasal sinusitis in children

Diagnosis of acute bacterial sinusitis in children depends on obvious clinical signs showing sinusitis or unexpectedly longer duration of any upper respiratory tract infection symptoms (>10-14 days). In children, sinusitis is a clinical diagnosis. Viral upper respiratory tract infections can lead to the same appearance of sinusitis on X-ray of paranasal sinuses. So, the physician should be carefully evaluating the X-rays. X-rays should be done in any case with recurrent sinusitis or any sinusitis with complicatons related to infection. The frequency of pneumococci with moderate penicillin-resistance is 20-25 % and high-level penicillin resistance is 3% in Turkey. Among H influenzae strains in Turkey, beta-lactamase producing strains cover about 8%. Amoxycillin is the first choice antibiotic in treatment. But, if the case age is under two- years, or is attending a kindergarten, or if there is a positive history for antibiotic usage in the last three months, amoxycillin should be used in high doses (80-90 mg/kg/d) in the management of these cases with high risk for resistant pneumococci. At the end of the first three days of treatment, if the case is not recovering, antibiotic modality should be changed into second or third level of choices. There is no data on clinical benefit of mucolytic syrups, antihistaminics, or decongestants. The only other treatment known to be beneficial is NaCl 0.9% nasal saline drops.

___

  • 1- Nash D, Wald E.Sinusitis.Ped Rev 2001 ;22:111-7.
  • 2. Gwaltney JAA. Acute community-aquired sinusitis. Gin Infect Dis 1996; 23:1209-25.
  • 3- File TM. The epidemiology of respiratory tract infections. Semin Res Intact 2000; 15:184-94.
  • 4- Brook lr Gooch WM, Jenkins SG, Pichichero ME, Reiner SAr Sher L, Yamauchi T. Medical management of acute bacterial sinusitis. Ann Otol Rhinol Laryngol 2000; 109:2-19.
  • 5- Conrad DA, Jenson HB. Management of acute bacterial rhinosinusitis. Curr Opin Pediatr 2002; 14:86-90.
  • 6- Wald ER. Sinusitis in children. NEJM 1992; 326:319-23.
  • 7- O'Brien KL, Dowell SF, Schwartz B, Marcy M, Philips WR, and Gerber MA. Acute sinusitis_ Principles of judicious use of antimicrobial agents. Pediatrics 1998; 101:174-7.
  • 8- Gwaltney JM, Hendley JO, Philips CD,Bass CR, Mygind N and Winther B. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 2000; 30:387-91.
  • 9- Çocuk Enfeksiyon Hastalıkları Derneği; Alt solunum yolu enfeksiyonları çalışma grubu raporu. Akut rinosinüzit. Çocuk Enfeksiyon Hastalıkları Derneği Yayınları; İstanbul, 2002; sayfa:67-76.
  • 10-Brook I. Bacteriologic features of chronic sinusitis in children. JAMA 1981; 246:967-9.
  • 11-Wald ER, Guerra N, and Carol B. Upper respiratory tract infections in young children: Duration of and frequency of complications. Pediatrics 1991; 87:129-33.
  • 12-AAP Subcomitte on management of sinusitis and committee on quality improvement. Clinical practice guideline: Management of sinusitis. Pediatrics 2001; 108:798-808.
  • 13-Bishai WR. Issues in the management of bacterial sinusitis. Otolaryngol Head Neck Surg 2002;127:S3-S9.
  • 14- Gürler N. Ülkemizde dirençli bakteriyel enfeksiyonların epidemiyolojisi. 25. Pediatri Günleri, 16-18 Nisan 2003, İstanbul, Kongre Kitabı sayfa: 99-117.
  • 15-Gür D, Özalp M, Sümerkan B, Kaygusuz A, Töreci K, Koksal İ, Över U, Söyletir G. Prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarhalis and Streptococcus pyogenes : Results of a muticentre study in Turkey. Int J Antimicrob Agents 2002; 19:207-11.
  • 16-Gur D, Guciz B, Hascelik G, Esel D, Sümerkan B, Over U, Söyletir G, Ongen B, Kaygusuz A, Töreci K. Streptococcus pneumoniae penicillin resistance in Turkey. J Chemother 2001; 13:541-5.
  • 17-Çiftçi E, Doğru Ü, Aysev D, İnce E, and Güriz H. Investigation of risk factors for penicillin-resistant Streptococcus pneumonia carriage in Turkish children. Pediatr Int 2001; 43:385-90.
  • 18-loannidis JP, and Lau J. AAP Technical report: Evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children:A systematic overview. Pediatrics 2001; 108:1 8.URL:http:// www.pediatrics.org/cgi/content/full/10 8/3/e57.
  • 19-Ünver Y Astmatik ve non-astmatik çocuklarda maksiller sinüzit. Uzmanlık Tezi İstanbul Üniversitesi, Çocuk Sağlığı Enstitüsü, İstanbul,1996.
  • 20- Kronemer KA and McAlister WH. Sinusitis and its imaging in pediatric population. Pediatr Radiol 1997; 27:837-46.
  • 21- McAlister WH, Parker BR, Kushner DJ, Babcock DS, Cohen HL, Gelfand MJ, et al. Sinusitis in pediatric population. ACR
  • 22-Engels EA, Terrin N, Barza M, and Lau J. Metaanalysis of diagnostic tests for acute sinusitis. J Clin Epidemiol 2000; 53:852-62.
  • 23-Wald ER, Chiponis D, and Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxycillin-clavulanate potassium in acute paranasal sinus infections in children: A doubleblind, placebo-controlled trial. Pediatrics 1986; 77:795-800.
  • 24-Poole MD, Jacobs MR, Anon JB, Marchant CD, Hoberman A, Harrison CJ. Antimicrobial guidelines for the treatment of acute bacterial rhinosinusitis in immunocompetent children. Int J Pediatr Otorhinolaryngol 2002; 63:1-13.
  • 25-Jacobs RF. Judicious use of antibiotics for common pediatric respiratory infections. Pediatr Infect Dis J 2000; 19:938-43.
  • 26-Morris P, Leach A. Antibiotics for persistent nasal discharge (rhinosinusitis) in children (Cochrane Review). Cochrane Database Syst Rev 2002; (4):CD001094.
  • 27-Topal B, Özsoylu Ş. Are antibiotics required for the treatment of acute sinusitis in children? Yeni Tıp Dergisi 2001; 18:S58-60.
  • 28-Goldsmith AJ, Roseenfeld RM. Treatment of pediatric sinusitis. Pediatr Clin North Am 2003; 50:413-26.
  • 29-İnanlı S, Öztürk Ö, Korkmaz M, Tutkun A, Batman Ç. The effects of topical agents of fluticasone propionate, oxymethazoline and 3% and 0.9% sodium chloride solutions on mucociliary clearence in the therapy of acute bacterial rhinosinusitis in vivo. Laryngoscope 2002; 112:320-5.